{
    "nctId": "NCT03704454",
    "briefTitle": "The Use of Pycnogenol\u00ae to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments",
    "officialTitle": "The Use of Pycnogenol\u00ae to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments",
    "overallStatus": "UNKNOWN",
    "conditions": "Climacteric; Menorrhagia, Menopausal, Menopause",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Menopause Rating Scale (MRS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient currently is undergoing treatment for cancer\n* Patient has menopausal symptoms induced either by surgical or medical (patient on tamoxifen or aromatase inhibitor) interventions for cancer\n* \\> 18 years of age\n* Willing to travel to a Legacy Health facility if necessary\n* Agree to attend study visits outside of standard of care visits, if needed\n* Willing to stop other supplements or medications that are aimed at treating menopausal symptoms at least 7 days before beginning study treatment\n* Willing to engage in pre/post testing and survey/phone calls\n\nExclusion Criteria:\n\n* Patient is currently undergoing chemotherapy treatment\n* \\< 18 years of age\n* Unable to comply with protocol\n* Unable to provide written informed consent\n* Investigator does not believe study participation is in the best interest of the patient\n* Patient had concurrent menopausal symptoms prior to the start of cancer treatment\n* Menopausal symptoms are unrelated to surgical or medical treatment of breast or gynecologic cancers",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}